Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance

James W. Antoon, Rongye Lai, Amanda P. Struckhoff, Ashley M. Nitschke, Steven Elliott, Elizabeth C. Martin, Lyndsay V. Rhodes, Nam Seung Yoon, Virgilio A. Salvo, Bin Shan, Barbara S. Beckman, Kenneth P. Nephew, Matthew E. Burow

Research output: Contribution to journalArticle

22 Scopus citations


Altered death receptor signaling and resistance to subsequent apoptosis is an important clinical resistance mechanism. Here, we investigated the role of death receptor resistance in breast cancer progression. Resistance of the estrogen receptor alpha (ER)-positive, chemosensitive MCF7 breast cancer cell line to tumor necrosis factor (TNF) was associated with loss of ER expression and a multi-drug resistant phenotype. Changes in three major pathways were involved in this transition to a multidrug resistance phenotype: ER, Death Receptor and epithelial to mesenchymal transition (EMT). Resistant cells exhibited altered ER signaling, resulting in decreased ER target gene expression. The death receptor pathway was significantly altered, blocking extrinsic apoptosis and increasing NF-kappaB survival signaling. TNF resistance promoted EMT changes, resulting in a more aggressive phenotype. This first report identifying specific mechanisms underlying acquired resistance to TNF could lead to a better understanding of the progression of breast cancer in response to chemotherapy treatment.

Original languageEnglish (US)
Article number539
JournalScientific reports
StatePublished - Aug 6 2012


ASJC Scopus subject areas

  • General

Cite this

Antoon, J. W., Lai, R., Struckhoff, A. P., Nitschke, A. M., Elliott, S., Martin, E. C., Rhodes, L. V., Yoon, N. S., Salvo, V. A., Shan, B., Beckman, B. S., Nephew, K. P., & Burow, M. E. (2012). Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Scientific reports, 2, [539].